Bausch Health Companies | Passività Correnti



Current Liabilities Cambiamento Data
Amgen USD 23.01B 91M 2025-03
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bausch Health Companies USD 4.26B 2.5B 2025-03
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Danaher USD 6.64B 153M 2025-03
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
Novo Nordisk 236.12B 27.76B 2025-03
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Prestige Brands USD 106.62M 4.08M 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zoetis USD 3.38B 27M 2025-03



Bausch Health Companies Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.